Dendreon to pursue sale or reorganization in bankruptcy

Dendreon Corp. files for Chapter 11 bankruptcy, which could lead to a sale or reorganization of its cancer drug operation.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.